Tympanometry Comparison of Diabetic Type I and Diabetic Type II Rats

نویسندگان

چکیده

Hearing impairment affects over two-thirds of adults with diabetes. We investigated whether rat models type 1 and 11 diabetes display impaired auditory function. Tympanometry measurements were conducted in Sprague-Dawley rats (control, n = 20), streptozotocin-induced I diabetic (n 20) at 42 - 56 days old; Zucker (Hos: ZFDM-Lean (fa/+, Type 2 Diabetic (ZFDM ZFDM-fa/fa); 20)), 90 old. All male. Control animals had normal A tympanograms. Tweny one (75%) the tympanic membranes group produced abnormal tympanograms: 46% B, 28% no peak found, 1% C. The ear canal lower left mice (0.19 ± 0.07) higher for II (0.23 0.15 ml) compared to controls 0.39 0.14 (0.2 0.12 respectively (P < 0.0001). compliances right (0.18 0.05 control (0.28 0.19 0.49 0.0001) respectively. In conclusion, exhibited tympanograms a highly functional middle system. mostly B less compliant Compliance was reduced control. Future studies should utilise histological methods alongside tympanometry. Sections could be used analyze ossicle size confirm differences. This information would useful avenues treatment options hearing loss

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Comparison of Diagnostic Value of Intrarenal Doppler Indices and Microalbuminuria for Detection of Diabetic Nephropathy in Type II Diabetic Patients

Background & Aims: Diabetes is the most common cause of renal insufficiency throughout the world. The main cause of renal failure in diabetic patients is microvascular endothelial injuries that is secondary to atherosclerosis and ischemia. The efficacy of renal Doppler indices such as resistive index (RI) and pulsetile index (PI) for the evaluation of intrarenal arteries has been shown. This st...

متن کامل

Evaluation of anti-diabetic activity of Glucova Active Tablet on Type I and Type II diabetic model in rats

BACKGROUND Glucova Active Tablet is a proprietary Ayurvedic formulation with ingredients reported for anti-hyperglycemic, anti-hyperlipidemic activity and antioxidant properties. OBJECTIVE Evaluation of anti-diabetic activity of Glucova Active Tablet on Type I and Type II diabetic model in rats. MATERIALS AND METHODS Experimental Type I diabetes was induced in 24 albino rats with intra-peri...

متن کامل

Effect of exercise and vitamin E on pain threshold in type I diabetic rats

Introduction: Oxidative stress is an important factor in the induction of diabetes complications especially peripheral neuropathy and hyperalgesia, and it has been proven that regular aerobic exercise and vitamin E have antioxidant effects. Therefore, this study was designed to examine effects of regular aerobic exercise and vitamin E on thermal pain threshold in streptozocin-induced diabeti...

متن کامل

Depression and Glycemic Control in Type II Diabetic Patients

Objective: Studies reported conflicting results&rsquo; regarding the status of depression and glycemic control in patients with type II diabetes(T2DM), therefore, this study was performed to determine the relationship between depression and glycemic control in T2DM patients. Materials and Methods: This cross-sectional study was performed on 150 T2DM patients referred to Yazd diabetes researc...

متن کامل

Diabetic papillopathy in type II diabetic patients.

PURPOSE To evaluate the patient characteristics and fundus findings of patients with type II diabetes presenting with diabetic papillopathy. METHODS The authors retrospectively reviewed the medical records of 3,235 patients with diabetes followed in their institution since 1986 and identified the patients with unilateral or bilateral transient disk swelling and without significant deteriorati...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of diabetes mellitus

سال: 2023

ISSN: ['2160-5858', '2160-5831']

DOI: https://doi.org/10.4236/jdm.2023.131006